GLP-Test Facilities

The following Test Facilities have been inspected by the Swiss Monitoring Authorities. It was found that they were operating in compliance with the GLP Principles at the time they were inspected. The Facilities are in the compliance monitoring programme of the authorities.

According to article 6 paragraph 2 of the Ordinance on Good Laboratory Practice (OGLP), the Test Facilites are re-inspected every two to three years on a routine basis.

The list is regularly updated according to article 14 OGLP. In case of doubt concerning the actual situation of a particular Facility please contact the notification authority for chemicals.

Test Facilities Last
Inspect.   
Areas of Expertise*
AnaPath GmbH
4625 Oberbuchsiten
AnaPath Services
4410 Liestal
Sep 2017 OTH
(histopathology)
AO Research Institute Davos
7270 Davos Platz
Nov 2015 TOX
Arcadis Schweiz AG
8952 Schlieren
Mar 2017 ECT, ENF, PCT
Bracco Suisse SA
1228 Plan-les-Ouates, Geneva
Mar 2016 ACC, TOX
b Sys GmbH
4108 Witterswil
March 2018 OTH
(Electrophysiology)
Celerion Switzerland AG
8320 Fehraltorf
Nov 2015 ACC
F.Hoffmann-La Roche Ltd.
Pharma Research
4070 Basel
Feb 2017 ACC, MUT, OTH
(pharmacokinetics, safety pharmacology, pathology evaluation)
Firmenich SA
Laboratoire de biodégradation
1211 Genève
Mar 2016 OTH
(biodegradation)
Givaudan SA
Ecotoxicology
1214 Vernier
Mar 2016 ENF, PCT
Idorsia Ltd.4123 Allschwil Nov 2015  ACC 
Innovative
Environmental Services (IES) Ltd.
4108 Witterswil
Aug 2017 PCT, ECT, ENF, RES, ACC, OTH
(in vitro metabolism/dermal penetration)
Institute for Biopharmaceutical
Research (IBR), Inc.
9548 Matzingen
Nov 2016 ACC, OTH
(pharmacokinetics, immunological
testing)
Intertek (Schweiz) AG
TechCenter Reinach
4153 Reinach
Dec 2016 PCT, ACC
LKC Switzerland Ltd
4414 Füllinsdorf
March 2018 OTH
(study direction of multisite residue studies)
Max Zeller Söhne AG
Zeller Preclinical Research
8590 Romanshorn
Sep 2015 OTH
(cytotoxicity, interactions)
MSRU Vetsuisse Faculty Zürich
8057 Zürich
Feb 2017 OTH
(biocompability and efficacy with medical devices and pharmaceuticals) 
Novartis Pharma AG
PCS/ Project Pathology
4002 Basel
Sep 2016 OTH (pathology review)
Philip Morris Products S.A.
Research and Development
PMI Product Testing
2000 Neuchâtel
Sep 2015 PCT, MUT, ACC, OTH
(in vitro toxicity)
SGS M-Scan SA
1228 Plan-les-Ouates
Nov 2016 ACC
Swiss BioQuant AG
4153 Reinach
Sep 2016 ACC
Syngenta Crop Protection AG
GLP Testing Facility WMU
4333 Münchwilen
Apr 2017 ACC, PCT
SYNLAB pharma institute AG
4127 Birsfelden
May 2017 ACC, OTH
(in vitro cytotoxicity)

Areas of Expertise:
PCT Physical-chemical testing
TOX Toxicity studies
MUT Mutagenicity studies
ECT Environmental toxicity studies on aquatic and terrestrial organisms
ENF Studies on behaviour in water, soil, and air; bioaccumulation
RES Residue studies
EMN Studies on effects on mesocosms and natural ecosystems
ACC Analytical and clinical chemistry testing
OTH Other studies, specify

Last modification 26.09.2016

Top of page